A Prospective, Open-label, Pivotal Study to Assess Spectacle Hearing Aid Safety and Efficacy

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Phase 2/Phase 3
SUMMARY

Following informed consent signature and upon verification of eligibility and execution of informed consent, subjects will be assigned a study code. The study comprises two groups. Screening visit will be conducted for both groups and include hearing test battery to assess hearing aid safety and efficacy

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adults aged 18 years and older

• Perceived mild to moderate hearing loss as indicated by at least 1 positive answer to any of the signs specified by FDA: a) You have trouble hearing speech in noisy places, b) You find it hard to follow speech in groups, c) You have trouble hearing on the phone. d) Listening makes youtired, e) You need to turn up the volume on the TV or radio, and other people complain it's too loud

• Wearing corrective glasses for daily use

• Cognitive ability to understand and follow study instructions.

• The main language used in social interactions is Hebrew

• Participants must be willing to use the investigational device according to the instructions for use during the study period

• Participants must be able to use a smartphone

Locations
Other Locations
Israel
Asssuta ramat hachayal
RECRUITING
Tel Aviv
Contact Information
Primary
Yael Corcos, MPH
yael@ay-impact.com
972-54-8106010
Time Frame
Start Date: 2025-07-27
Estimated Completion Date: 2026-12
Participants
Target number of participants: 89
Treatments
Experimental: Active
Spectacle Hearing Aid
Related Therapeutic Areas
Sponsors
Leads: Nuance Hearing
Collaborators: Assuta Medical Center

This content was sourced from clinicaltrials.gov